A recent study by Ping et al. indicated the absence of BRAF mutations involving exon 15 in acute myeloid leukemia (AML), myelodysplastic syndromes (MDS), and myeloproliferative neoplasms (MPN) within a cohort of 578 patients with myeloid neoplasms [4]. Here, BRAF is linked to myeloproliferative disorder.